by | Jul 5, 2024 | Uncategorized
CHICAGO — Sandra Mazzoni, DO, spoke with Healio about a study presented at ASCO Annual Meeting she was part of investigating the use of AI to determine any patterns in how patients with multiple myeloma respond to therapy.“They used a database of hundreds of [patients...
by | Jul 5, 2024 | Uncategorized
Source: CureToday articles Treatment with the CAR-T cell therapy Carvykti has been reported to improve survival among some patients with multiple myeloma. Read More
by | Jul 5, 2024 | Uncategorized
CHICAGO — In this video, Sandra Mazzoni, DO, discusses the use of minimal residual disease, or MRD, testing in multiple myeloma.“There’s a lot of hot topics right now in myeloma in general,” Mazzoni, hematologist with the Cleveland Clinic, said.She highlighted updates...
by | Jun 30, 2024 | Uncategorized
Source: CureToday articles “For their love, support and kindness, I am eternally grateful and blessed to have such people in our lives,” said Levinson. Read More
by | Jun 25, 2024 | Uncategorized
CHICAGO — In this video, Adam Cohen, MD, spoke to Healio about the use of minimal residual disease testing to determine cessation of therapy in patients with multiple myeloma.The MRD2STOP trial, presented at ASCO Annual Meeting, observed multiple factors in patients...
by | Jun 24, 2024 | Uncategorized
CHICAGO — In this video, Adam Cohen, MD, spoke to Healio about the role of quadruplet induction regimens for transplant-ineligible patients with multiple myeloma.IMROZ and BENEFIT, randomized phase 3 trials presented at ASCO Annual Meeting, investigated the...
